SPEAKER SPOTLIGHT

Dr. Timothy Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. He is the MGH Trustees Chair in Addiction Medicine and a professor of psychiatry at Harvard Medical School. Dr. Wilens earned his MD at the University of Michigan Medical School in Ann Arbor and completed his residency in child, adolescent, and adult psychiatry at Mass General. Dr. Wilens’ research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; embedded health care models, digital therapeutics, and the pharmacotherapy of ADHD across the lifespan. He has published more than 325 peer-reviewed articles, concerning these and related topics. He has also coedited more than 80 book chapters, 5 books, and 350 abstracts and presentations for national and international scientific meetings. Dr. Wilens is a distinguished fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry and is on the editorial boards or is a scientific reviewer for more than 35 journals.
Have you Registered?
ASCP 2023 Psychopharmacology Update: State-of-the-Art Fall Meeting

Register by August 10- September 13, 2023, for advanced registration rates! 

October 7-8, 2023
InterContinental New York Times Square, New York, NY

ASCP's Psychopharmacology Update: State-of-the-Art Fall Meeting will be held as an in-person only meeting. Outstanding faculty will update you on the very latest in clinical psychopharmacology.

Register by August 10- September 13, 2023, for advanced registration rates 

This program is designed to provide state-of-the-art education on new developments in psychopharmacology for psychiatrists and other professionals already knowledgeable about drug treatment of psychiatric disorders. At the conclusion of the program, the participants should have an enhanced ability to correctly assess patients in need of psychopharmacologic intervention and properly administer state-of-the-art treatment.

2023 Fall Meeting Registration Rates
Registration Fees
ASCP Member*
Non-Member
Residents/Trainees**
Advanced
August 10th - September 13th
$500
$625
$100
Standard
September 14th - October 8th
$525
$650
$100
Hotel Reservations
*Discounted rate available until Wednesday, September 13, 2023 or until sold out*

The Intercontinental New York Times Square
300 W 44th St New York, NY, 10036

  • Click here to reserve your sleeping room or call toll-free at 866-875-1978. Any available agent will be happy to assist you.  
  • Sleeping rooms are available at the discounted rate of $369 per night. 
  • The discounted rate is available until Wednesday, September 13th, or until sold out, whichever comes first. Click here to reserve today!
  • Check-in time is 3:00 pm and check-out time is 11:00 am.
Meeting Information
  • Earn up to 16 AMA PRA Category 1 Credit(s)™.
  • Outstanding faculty will update you on the very latest in clinical psychopharmacology. Click here to view the presenters and topics.
  • Valuable networking opportunities with colleagues and speakers from the field of psychopharmacology.  
* If not currently an ASCP member, you may join during the registration process and pay the discounted rate.
** To get the Resident rate, you must join ASCP as a Resident Member. (Membership is complimentary.)

Groups of 10 or more from the same institution are eligible for a 20% discount on registration.
For more information, please contact ASCP's Executive Office at info@ascpp.org.

Continuing Education Credits

The American Society of Clinical Psychopharmacology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
The American Society of Clinical Psychopharmacology takes responsibility for the content, quality and scientific integrity of this CME Activity.
 
In 2023, the American Society of Clinical Psychopharmacology (ASCP) designates this live meeting for a maximum of 16 AMA PRA Category 1 Credit(s)™. Each physician should claim only those hours of credit that (s)he actually spent in the educational activity.
 
The American Board of Psychiatry and Neurology has reviewed the 2023 Psychopharmacology: State-Of-The-Art Fall Meeting and has approved this program as part of a comprehensive self-assessment program, which is mandated by the ABMS as a necessary component of maintenance of certification.
American Society of Clinical Psychopharmacology| (615) 649-3085 | (888) 417-3311 | info@ascpp.org | www.ASCPP.org